by Discovery | Feb 18, 2022 | Featured Collaboration
Charlottesville, Virginia – February 2022 KeViRx, Inc. (“KeViRx”) has been selected to join Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), a component of...
by Discovery | Sep 15, 2016 | Featured Collaboration, Uncategorized
A drug discovery team headed by Webster Santos, Associate professor of Chemistry and member of the Virginia Tech Center for Drug Discovery, and Kevin Lynch, Professor of Pharmacology at the University of Virginia, School of Medicine, is developing inhibitors of...
